1 / 12

Changing the Incidence of Glomerular Diseases in Adults

Changing the Incidence of Glomerular Diseases in Adults. G. Braden, J. Mulhern, M. O’Shea, S. Nash, A. Ucci & J. Germain AJKD, Vol 35 No.5:2000; pp 878-83. Background. For the last 50 years, MN was the leading cause of Idiopathic NS in up to .5 of W and AA adults, whereas FSGS was .1-.15

kineta
Télécharger la présentation

Changing the Incidence of Glomerular Diseases in Adults

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Changing the Incidence of Glomerular Diseases in Adults G. Braden, J. Mulhern, M. O’Shea, S. Nash, A. Ucci & J. Germain AJKD, Vol 35 No.5:2000; pp 878-83 November 2000, Journal Club

  2. Background • For the last 50 years, MN was the leading cause of Idiopathic NS in up to .5 of W and AA adults, whereas FSGS was .1-.15 • 3 academic Ctrs. reported  FSGS in AA • No info on sm. urban (< 150 K population) & rural areas • No info on Hispanics

  3. Methods • Renal Bx & chart review from 1974-94 at Baystate Med. Ctr. in Springfield, Mass. • >18 y.o, 2 gm proteinuria/day, 5 yr intervals • Excluded: IVDA, HIV, SS, VUR, meds, tumors, Hep B, MPGN (2o to cryoglob or hepatitis), collagen, SLE, Crescentic GN, Acute Prolif. GN, Focal necrotizing GN, vasculitis, amyloidosis & fibrilary GN

  4. Results • Sample: 965, eligible n = 616 adults • AA catchment pop. in 20 years .056  .065 • 2o FSGS went from 0 in the 1st and 2nd quartiles, to .12 (3rd q) to .06 (4th q) • 2o MN: .3 in the 1st.12 .15 .06 • No sig.  in other 1o Glomerulopathies • 1990-94  new FSGS 15 vs. MN 7 (p<.05)

  5. Discussion (1):Idiopathic FSGS Increase •  Unlikely due to detection (tissue levels on light microscopy/Bx = in 20 years) •  Unlikely due to frequency of 2o causes of FSG or MN because these patients  along with the idiopathic FSGS cases. • No  in 2o MN that could  Idiopathic MN

  6. Discussion (2):Idiopathic FSGS Increase • FSGS  in AA & H (significantly) & in W • No  in age and sex distribution in 20 y. • Inclusion of all 2 g/d proteinuria, not all patients had NS  overestimation • Most Hispanics from Puerto Rico

More Related